↓ Skip to main content

Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe…

Overview of attention for article published in BMC Geriatrics, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs
1 blog
twitter
17 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
117 Mendeley
Title
Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)
Published in
BMC Geriatrics, April 2019
DOI 10.1186/s12877-019-1122-2
Pubmed ID
Authors

Aina Soler, Guillem Amer, Alicia Leiva, Joana Ripoll, María Angeles Llorente, Alfonso Leiva, Joana Maria Taltavull, Rosa Molina, Joan Llobera

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 117 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 11%
Student > Bachelor 13 11%
Student > Postgraduate 8 7%
Student > Master 8 7%
Student > Ph. D. Student 4 3%
Other 12 10%
Unknown 59 50%
Readers by discipline Count As %
Medicine and Dentistry 17 15%
Nursing and Health Professions 15 13%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Psychology 4 3%
Neuroscience 3 3%
Other 12 10%
Unknown 58 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2020.
All research outputs
#2,042,806
of 25,613,746 outputs
Outputs from BMC Geriatrics
#445
of 3,691 outputs
Outputs of similar age
#44,858
of 367,453 outputs
Outputs of similar age from BMC Geriatrics
#14
of 79 outputs
Altmetric has tracked 25,613,746 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,691 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.